Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
CKD affects >10 % of the general population worldwide and has emerged as one of the leading cause of death and suffering in the 21St Century. Apart from the traditional risk factors , the religious beliefs and socio-demographic profile of the CKD population must be studied for better prevention and treatment of the disease process
Objective
1) To study the clinical spectrum and socio-demographic profile of CKD patients .
2) To assess any difference in CKD etiology in our part of the country based on gender, ethnicity, religion.
It is a Hospital based single- centre retrospective study conducted in the Department of Nephrology, Gauhati Medical College and Hospital for a period of 12 months from May 2022 to May 2023. A total of 3860 patients of CKD stage 4 and stage 5 attending the Nephrology Dept were taken up as the study population. History, relevant clinical and laboratory data, socio-demographic profile and religious beliefs of the study participants were obtained from the medical records.
The frequency distributions were tested for statistical uniformity using Chi Square Test for Goodness Of Fit at 0.05 significance level. A p value less than 0.05 is considered as statistically significant .
Of the 3860 CKD patients , 3.57% of the study cohort belonged to CKD stage 4, 4.87 % belonged to CKD stage 5(ND) and 91.55% were in CKD stage 5(D). Males comprised 68.81% and females 31.19% of the study population with a male: female ratio of 2.2: 1 (p <0.05). Majority of the patient population belonged to the age group of 40-60 years (57.87%) followed by the age group of >60 years (28.55%).
71.81 % of the patients resided in the rural areas and 28.18% in urban areas (p <0.05).
Majority of the study population belonged to socioeconomic class IV (42.79%) and Class III (33.52%).
Among the religious beliefs, most of the patients were believers of Hinduism (75.34%) followed by Islamics (20.26%). Christianity was followed by 4.4% of the study population.
Tribal community comprised 3.88% of the study cohort . Our study is a first of a kind where the religious profile of the CKD patients was studied and their CKD etiology compared. DKD was the most common etiology of CKD in all the religions. However, the followers of Islam and Christianity had hypertensive nephropathy as the 2nd common etiology of CKD whereas in the followers of Hinduism, CGN was the 2nd common etiology . In the tribal community, CTID was the leading cause of CKD followed by CGN and then DKD. The etiology of CKD was unknown in 7.87% of the study population. The all-cause mortality was seen in 96 patients (2.48%) in our study and Cardiovascular disease was the most common cause of death (60.41%) followed by sepsis (25%) (p<0.05).
CKD has emerged as one of the most prominent causes of death and suffering in the present day. To the best of our knowledge, this is a first of its kind study in North-East India which has tried to explore any difference in CKD prevalence based on gender, age, ethnicity, religious beliefs, socio-economic status and locality and hence, may provide a significant input for retarding the progression of CKD.
